Antidepressant warnings FDA: To use secure when the drug is begun

The Food and Drug Administration (FDA) sometimes communicated the warnings on drugs, when a drug previously approved of is demonstrated of being potentially injurious. And ' possible for the new effects collaterals and other problems to go up after drugs they have been approved of and on the market for a po'. Once that it comes emitted an warning (if the drug does not come removed from the market), a careful continuous monitoring. Why I am writing on this argument? In 2004, an warning has been published care l' antidepressant drug use in the children and the adolescents. This warning successively is widened in order to include the young people adults (between 18 and 24). Not there was the worry that the antidepressants could increase to the risk of suicide in these groups of age (such risk have not been found in those of advanced age to 24). L' FDA recommends in particular:

■ someone that it begins to be dealt with antidepressant drugs, in particular those in treatment for the depression, must be observed gives close for the worsening of the depression and in order to increase to the thought or suicidario behavior. ■ Un' careful observation of the adults can be particularly important when the antidepressant drugs are started for the first time or when the doses for their antidepressant drugs have been changed. ■ adults whose symptoms get worse during the treatment with antidepressants, between which an increase of thoughts you kill or behavior, must be estimated for their sanitary staff. He prays himself to take the time in order to examine upgrades them effects collaterals with your supplier of medical cures. And ' important that adequately its disease and options of treatment, comprised are informed approximately the risks, benefits and alternatives.